To generate long term capital appreciation through investments made primarily in equity & equity related securities of companies forming part of Healthcare sector. However, there can be no assurance or guarantee that the investment objective of the scheme would be achieved.
Expert-managed portfolios tailored to your financial goals and risk appetite.
| Sector Funds | 1M | 3M | 6M | 9M | 1Y | 2Y | 3Y | 4Y | 5Y | 10Y | ALL |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Fund returns | -5.27% | -5.77% | 5.31% | 6.11% | 1.04% | 2.26% | 18.9% | 20.66% | 14.21% | N/A | 18.53% |
| Category returns | -7.54% | -3.42% | 10.54% | 13.4% | 8.01% | 3.9% | 18.22% | 18.48% | 12.78% | 13.01% | N/A |
| Absolute returns | -5.27% | -5.77% | 5.31% | 6.11% | 1.04% | 4.59% | 68.19% | 112.05% | 94.38% | N/A | 308.2% |
| Rank within category | 1/19 | 17/18 | 16/18 | 17/18 | 16/17 | 8/14 | 5/12 | 2/10 | 2/9 | N/A | N/A |
| Sector Funds | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|
| Yearly returns | N/A | 4.66% | 71.37% | 18.23% | -8.5% | 41.31% | 48.14% | -0.8% | 2.54% |
| Q1 returns | N/A | 2.63% | -7.74% | -2.09% | -6.01% | -2.76% | 11.48% | -9.79% | -8.04% |
| Q2 returns | N/A | -4.93% | 37.11% | 17.81% | -8.79% | 16.95% | 6.66% | 8.81% | 17.59% |
| Q3 returns | N/A | -2.39% | 22.32% | 4.01% | 6.63% | 11.79% | 21.11% | -1.19% | -1.56% |
| Q4 returns | -5.36% | 9.88% | 10.75% | -1.46% | 0.1% | 11.16% | 2.87% | 2.29% | -3.68% |
1% on or before 15D, Nil after 15D
| Alpha | 1.16511 |
| Beta | 0.703 |
| Sharpe Ratio | 0.296656 |
| Sortino Ratio | 0.656842 |
| R-Squared | 0.3791 |
| Tracking Error | 3.4014 |
| Downside Risk | 16.5914 |
| Std. Deviation (Annualised) | 14.208 |
| Sector Funds | 1M | 3M | 6M | 9M | 1Y | 3Y | 5Y | 10Y | ALL | Fund Size (Cr) | Exp. Ratio | Sharpe | Risk |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HDFC Pharma and Healthcare Fund - Regular Plan - Growth | -8.18% | -2.85% | 13.49% | 19.65% | 16.65% | 26.3% | N/A | N/A | 26.16% | 3,501.37 | 2.11 | 0.45 | Very High |
| SBI Healthcare Opportunities Fund - Regular Plan - IDCW | -7.91% | -3.95% | 12% | 16.9% | 9.98% | 20.31% | 16% | 12.88% | 16.36% | 5,870.00 | 1.99 | 0.33 | Very High |
| UTI Healthcare Fund - Regular Plan - IDCW | -8.04% | -4.49% | 10.8% | 14.7% | 7.94% | 19.65% | 13.41% | 12.86% | 14.71% | 1,429.84 | 2.22 | 0.32 | Very High |
| Mirae Asset Healthcare Fund - Regular Plan - Growth | -6.65% | -2.37% | 10.95% | 15.8% | 10.86% | 19.1% | 13.11% | N/A | 19.31% | 3,494.44 | 2.04 | 0.30 | Very High |
| ICICI Prudential Healthcare Fund - Growth Current | -5.27% | -5.77% | 5.31% | 6.11% | 1.04% | 18.9% | 14.21% | N/A | 18.53% | 6,861.20 | 2.08 | 0.30 | Very High |
| LIC MF Healthcare Fund - Regular Plan - Growth | -8.31% | -3.16% | 10.44% | 10.22% | 4.45% | 18.2% | 9.97% | N/A | 16.14% | 99.36 | 2.67 | 0.28 | Very High |
| DSP Healthcare Fund - Regular Plan - Growth | -5.87% | -2.13% | 13.11% | 11.93% | 9.74% | 17.47% | 13.29% | N/A | 20.34% | 3,750.04 | 2.05 | 0.29 | Very High |
| Aditya Birla Sun Life Pharma & Healthcare Fund - Regular Plan - Growth | -7.92% | -5.04% | 8.82% | 11.15% | 7.84% | 16.89% | 11.54% | N/A | 18.16% | 1,077.52 | 2.29 | 0.27 | Very High |
| Quant Healthcare Fund - Regular Plan - Growth | -7.41% | -1.49% | 10.61% | 18.21% | 9.71% | 16.57% | N/A | N/A | 17.69% | 424.53 | 3.13 | 0.23 | Very High |
| Tata India Pharma & Healthcare Fund - Regular Plan - Growth | -7.42% | -6.38% | 5.15% | 4.71% | -0.23% | 15.22% | 11.84% | 12.5% | 11% | 1,511.49 | 2.37 | 0.23 | Very High |
| Name | Sector | Instrument | Assets % |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 11.49% |
| Dr. Reddy's Laboratories Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 9.73% |
| Cipla Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 5.79% |
| Biocon Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 5.33% |
| Mankind Pharma Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 5.04% |
| Alkem Laboratories Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 4.81% |
| Medplus Health Services Ltd. | Retailing | Domestic Equities | 4.31% |
| TREPS | Cash & Cash Equivalents and Net Assets | 4.25% | |
| Cohance Lifesciences Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 4.06% |
| Divi's Laboratories Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 3.78% |
| Syngene International Ltd. | Healthcare Services | Domestic Equities | 3.50% |
| Dr. Agarwal's Health Care Ltd. | Healthcare Services | Domestic Equities | 2.66% |
| Max Healthcare Institute Ltd. | Healthcare Services | Domestic Equities | 2.63% |
| Abbott India Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 2.54% |
| Alembic Pharmaceuticals Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 2.50% |
| Pfizer Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 2.42% |
| Apollo Hospitals Enterprise Ltd. | Healthcare Services | Domestic Equities | 2.30% |
| Gland Pharma Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 1.97% |
| Akums Drugs & Pharmaceuticals Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 1.91% |
| Lupin Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 1.88% |
| Astrazeneca Pharma India Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 1.85% |
| Blue Jet Healthcare Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 1.83% |
| Indegene Ltd. | Healthcare Services | Domestic Equities | 1.74% |
| Metropolis Healthcare Ltd. | Healthcare Services | Domestic Equities | 1.65% |
| Rainbow Children's Medicare Ltd. | Healthcare Services | Domestic Equities | 1.29% |
| Fine Organic Industries Ltd. | Chemicals & Petrochemicals | Domestic Equities | 1.21% |
| Thyrocare Technologies Ltd. | Healthcare Services | Domestic Equities | 1.17% |
| Aarti Drugs Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 1.17% |
| Medi Assist Healthcare Services Ltd. | Insurance | Domestic Equities | 1.06% |
| Alivus Life Sciences Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.97% |
| Hikal Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.95% |
| Sanofi Consumer Healthcare India Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.93% |
| Manipal Health Enterprises Ltd. | Healthcare Services | Domestic Equities | 0.87% |
| Entero Healthcare Solutions Ltd. | Retailing | Domestic Equities | 0.74% |
| Laxmi Dental Ltd. | Healthcare Equipment & Supplies | Domestic Equities | 0.68% |
| FDC Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.66% |
| Windlas Biotech Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.57% |
| Indraprastha Medical Corporation Ltd. | Healthcare Services | Domestic Equities | 0.47% |
| Indoco Remedies Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.43% |
| Natco Pharma Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.02% |
| Cash Margin - Derivatives | Cash & Cash Equivalents and Net Assets | 0.01% | |
| Net Current Assets | Cash & Cash Equivalents and Net Assets | -3.16% | |
| Total | 100.00% | ||
He is associated with ICICI Prudential Asset Management Company Limited from June 2010. Prior to working in Investments function, he was working in the Operations Department of the AMC.
Get personalized portfolio management services designed to grow and protect your wealth.
ChatGPT
Claude
Perplexity
